HEALTH

Biocodex: Yeast-based probiotics can be used in conjunction with antibiotics

BY Michael Johnsen

SAN BRUNO, Calif. — Biocodex last week sought to set the record straight regarding the use of probiotics with antibiotics. 

"There is a common myth that probiotics can’t be used with antibiotics," stated Kerry Neville, a registered dietitian in Seattle. "In fact, there are different probiotic options available that can be beneficial before, during, and after antibiotic use, like Florastor."

While it is commonly agreed that probiotic supplements can be a beneficial addition to the daily diet, contradictory messages may leave consumers confused about how to incorporate a probiotic into their routine, Biocodex noted. "This is particularly true for those looking to support an immune system that has been weakened by illness or antibiotic use," the company stated. "Use of a yeast-based probiotic can benefit the body during and after antibiotic use."

Because antibiotics attack all bacteria, they often upset the balance of the body by depleting the body’s naturally existing good bacteria in addition to any invasive bacteria. This can leave the body more vulnerable to infection. "While there may be concerns surrounding using a bacteria-based probiotic and simultaneous use of antibiotics, because yeast-based probiotics are not compromised, they can continue to support digestive health even when it is weakened from antibiotics," Neville said. "Incorporation of a yeast-based probiotic consistently supports your body before, during and after illness and antibiotic use.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Sierra Research Labs licenses distribution of SeroVital-hgh through GNC to Novex Biotech

BY Michael Johnsen

NEW YORK — Demand for SeroVital-hgh — a proprietary amino acid compound developed by Sierra Research Labs — has spiked in the past month, in part due to recent exposure on news channels like CNN and on news programs like "The Today Show," the company announced last week. To help meet demand, the company on Dec. 21 announced distribution expansion through GNC. 

According to the company, the dietary supplement encourages the pituitary gland to increase growth hormone production at a more youthful rate, naturally, without drugs or synthetic hormone injections. The product is distributed through prestige retailers Ulta and Sephora. The supplement is available through GNC under the brand name Growth Factor-9. 

"With all the recent media coverage, sales have gone through the roof and our suppliers have been having trouble keeping up," stated Kerry Pack, a communications specialist with Sierra. "So we’re thrilled to announce that we’ve recently issued a … license to sports supplement company Novex Biotech, which will sell the compound as Growth Factor-9 exclusively at GNC," she said. "This will give consumers an extra avenue to get their hands on our proprietary formula." 

Responding to skeptics suggesting the claims behind the Sierra formula sound too good to be true, Pack said, "You can’t sit on the couch eating French fries all day and expect this formula to work like a ‘magic pill.’ It’s designed to be one part of a healthy lifestyle. Plus, it needs to be taken on an empty stomach so the amino acids in food can’t interfere with the way the proprietary formula works."

 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Study: Stroke survivors lacking antioxidant carotenoids in their gut flora

BY Michael Johnsen

GOTHENBURG, Sweden — Researchers at the University of Gothenburg along with the Chalmers University of Technology earlier this month demonstrated that an altered gut microbiota in humans is associated with symptomatic atherosclerosis and stroke. 

These findings were presented in a study published in Nature Communications on Dec. 4.

The researchers compared a group of stroke patients with a group of healthy subjects and found major differences in their gut microbiota. In particular, they showed that genes required for the production of carotenoids were more frequently found in gut microbiota from healthy subjects. The healthy subjects also had significantly higher levels of a certain carotenoid in the blood than the stroke survivors.

Carotenoids are a type of antioxidant, and it has been claimed for many years that they protect against angina and stroke. Thus, the increased incidence of carotenoid-producing bacteria in the gut of healthy subjects may offer clues to explain how this affects disease states.

Carotenoids are marketed today as a dietary supplement. The market for them is significant, researchers noted, but clinical studies of their efficacy in protecting against angina and stroke have produced varying results.

Jens Nielsen, professor of systems biology at Chalmers, suggested that it may be preferable to take probiotics that contain types of bacteria that produce carotenoids.

"Our results indicate that long-term exposure to carotenoids, through production by the bacteria in the digestive system, has important health benefits," Nielsen noted. "These results should make it possible to develop new probiotics. We think that the bacterial species in the probiotics would establish themselves as a permanent culture in the gut and have a long-term effect."

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?